Compare MasterCard Inc (MA) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasterCard Inc vs Nuwellis Inc — how do they compare? MasterCard Inc trades at $574.4 (market cap $499.38B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: MasterCard Inc is far larger — about 226990.9× Nuwellis Inc's market cap, and MasterCard Inc pays a 0.61% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold MasterCard Inc for 134 Days and Nuwellis Inc for 26 Days on average.
| MA | NUWE | |
|---|---|---|
Market Cap | $499.38B | $2.20M |
Volume | 1,862,680 | 121,544 |
Sector | Financials | Health |
52-Week High | $599.86 | $146.65 |
52-Week Low | $471.55 | $0.68 |
Typical Hold Time | 134 Days | 26 Days |
Enterprise Value | $512.41B | -$1.52M |
Dividend Yield | 0.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $574.76, up 1.44% with strong bullish technical signals and consistent earnings beats. The stock shows robust fundamentals with 46.3% net margins and 241.5% ROE, supported by growing institutional interest. Recent news highlights Mastercard's AI and digital payment initiatives, while analyst consensus remains strongly bullish with an $666.67 price target.
Outlook remains positive given earnings momentum and strategic positioning in digital payments, though competition from emerging payment technologies presents a key risk. The stock offers growth potential but requires monitoring of payment industry disruption and macroeconomic factors affecting consumer spending.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
